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Edited by Ulf-Ingo Flu¨ggeAbstract Under hypertonic conditions the induction of
SLC38A2/SNAT2 leads to the stimulation of transport system
A and to the increase in the cell content of amino acids. In hyper-
tonically stressed human ﬁbroblasts transfection with two si-
RNAs for SNAT2 suppressed the increase in SNAT2 mRNA
and the stimulation of system A transport activity. Under the
same condition, the expansion of the intracellular amino acid
pool was signiﬁcantly lowered and cell volume recovery mark-
edly delayed. It is concluded that the up-regulation of SNAT2
is essential for the rapid restoration of cell volume after hyper-
tonic stress.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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To counteract hypertonic stress, cells activate a complex ar-
ray of mechanisms, collectively indicated as regulatory volume
increase (RVI, [1,2]). This response produces an accumulation
of osmotically active compounds, called organic compatible
osmolytes, that leads to the recovery of cell volume and the de-
crease of intracellular ionic strength.
During RVI several transduction pathways are activated
and the expression of a number of genes is induced [3]. In par-
ticular, transporters for organic osmolytes, such BGT1 for
betaine, TAUT for taurine, and SMIT for myo-inositol are
up-regulated (see [4,5] for review). Several reports have also in-
volved amino acid transport system A, a sodium dependent
mechanism referable to SNAT transporters encoded by
SLC38 gene family [6], in cell volume recovery after hypertonic
stress (see [7] for review). Under the same conditions, also
NKCC co-transporter is stimulated and accumulation of
potassium chloride has been proposed as a rapid device to
counteract osmotic stress [8,9].Abbreviations: BGT1, betaine/GABA transporter; NKCC, Na(+)-
K(+)-2Cl() cotransporter; RVI, regulatory volume increase; SMIT,
sodium/myo-inositol cotransporter; SNAT, sodium-coupled neutral
amino acid transporter; TAUT, taurine transporter
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doi:10.1016/j.febslet.2005.05.002The discrimination of the relative contributions of single
mechanisms to the volume recovery process has been diﬃcult.
Many adaptations require changes in gene expression and can
be blocked with inhibitors of macromolecular syntheses [10].
However, these compounds are not speciﬁc.
In this report, we employ small interfering RNAs (siRNAs)
to suppress speciﬁcally the hypertonic induction of SLC38A2/
SNAT2, the ubiquitous member of SLC38 gene family, so as
to discriminate its role in RVI of cultured human ﬁbroblasts.2. Materials and methods
2.1. Cells and incubations
Cultured human ﬁbroblasts were grown in Dulbeccos modiﬁed Ea-
gle medium (DMEM), supplemented with 10% fetal bovine serum
(FBS). The osmolality of complete growth medium (isotonic DMEM)
was 306 ± 12 mosmol/kg.
For transport and volume experiments, cells were seeded in 96-well
multiwell dishes (Falcon) at a density of 10 000 cells/well. For qRT-
PCR and analysis of amino acid pool cells were seeded in 12-well
dishes at a density of 50 000 cells/cm2.
Hypertonic treatment consisted in the incubation in DMEM supple-
mentedwith 100 mMsucrose (hypertonicDMEM,405 ± 9 mosmol/kg).
2.2. SNAT2 siRNAs preparation and transfection
Ambion (Austin, TX) was the source of the three siRNAs against
human SLC38A2 (NM_018976): SNAT2_1 (sense GCGACUUCAA
CUACUCCUAtt; antisense UAGGAGUAGUUGAAGUCGCtg;
siRNA ID 43618), SNAT2_2 (sense GCAAGCUGCUCUGAAA
AGCtt; antisense GCUUUUCAGAGCAGCUUGCtt; siRNA ID
43690), and SNAT2_3 (sense GAAUGAUGAAUGUGUCCAAtt;
antisense UUGGACACAUUCAUCAUUCtt; siRNA ID 43761). Hu-
man ﬁbroblasts were plated the day before transfections and grown to
50–70% conﬂuence. Transfections were carried out according to si-
PORT Amine siRNA Transfection Protocol (Ambion). Negative con-
trol consisted of a scrambled siRNA with no similarity to human gene
sequences (Negative Control #1 siRNA, Ambion).
2.3. Transport activity, cell volume, and intracellular amino acids
Transport activity of system A was determined from the initial inﬂux
(1 min) of the system A-speciﬁc substrate 2-methyl-aminoisobutyric
acid ([14C]-MeAIB, 100 lM, 1 lCi/ml). The transport activities of sys-
tems XAG and ASC were determined from the inﬂux of, respectively,
[3H]-L-aspartate (10 lM, 3 lCi/ml, uptake time 1 min, [11]) and [3H]-
L-threonine (50 lM, 1 lCi/ml, uptake time 30 s, [12]). Assay procedure
was described previously [13].
Cell volume was estimated from the distribution space of urea,
according to a method previously validated in cultured human ﬁbro-
blasts [13]. The intracellular amino acid pool was determined by HPLC
analysis with a Biochrom 20 Amino Acid Analyzer (Amersham Phar-
macia Biotech) after cell extraction in a 5% solution of acetic acid in
ethanol, as described previously [14].blished by Elsevier B.V. All rights reserved.
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Total RNA, extracted with OMNIzole (Euroclone SpA, Pero (MI),
Italy), was reverse transcribed into cDNA using SuperScripte III Re-
verse Transcriptase (Invitrogen Srl, S. Giuliano Milanese (MI), Italy)
according to the manufacturers instructions. For real time PCR, ali-
quots of 20 ng of cDNA were ampliﬁed in Platinum Quantitative
PCR SuperMix UDG (Invitrogen Srl) with predesigned primers and
speciﬁc FAMe labelled TaqMan MGB probes for SNAT2 or the
housekeeping gene b2-microglobulin (b2M) (Assay-on-Demande, Ap-
plied Biosystems). Two ampliﬁcations for each transcript were per-
formed. A no-template, no-reverse transcriptase control was included
in each experiment.
Quantitative PCR was performed using a 36-well Rotor-Gene
3000e (Corbett Research, Software Rotor-Gene 3000, version
5.0.60, Mortlake, Australia) with the following thermoproﬁle: initial
step at 50 C for 2 min, 95 C for 2 min, and 40 cycles, consisting of
15 s-denaturation steps at 95 C and an unique annealing/extension
step at 60 C for 30 s. The analysis of data was performed according
to the relative standard curve method [15].
Data are expressed as SNAT2 expression normalized to the b2M
expression detected in the same cDNA mixture.
2.5. Materials
Serum was obtained from Gibco. Sigma was the source of culture
medium (DMEM, D5523). This formula contains 4 mM of glutamine,
while aspartate, alanine, proline and asparagine are not present. Per-
kin–Elmer was the source of 2-[methyl-14C]aminoisobutyric acid
(32 mCi/mmol) and Amersham Pharmacia Biothech was the sourceFig. 1. Eﬀect of SNAT2 siRNAs on amino acid transport activity and SNA
transfected as detailed in the single panels. At the end of the transfection
indicated. (A) Cells were transfected with 100 nM of the indicated siRNAs fo
6 h, uptake of MeAIB was measured as described under Section 2. (B) Cells w
scrambled and further cultured for 24 or 48 h, as indicated. Cells were then
uptake was measured. (C) Lysates of cells, transfected for 48 h as in (B) and in
for quantitative RT-PCR to assess SNAT2 mRNA levels. (D) Cells were tran
after a 6 h incubation under isotonic or hypertonic conditions. For Panels A, B
representative experiment. The experiment was repeated three times with com
comparing cells incubated under hypertonic conditions for 6 h vs. cells unde
conditions: \P < 0.05; \\P < 0.01; ns, not signiﬁcant. Panel C reports data froof [2,3-3H]-L-aspartate (39 Ci/mmol) and [3-3H]-L-threonine (15 Ci/
mmol). Unless otherwise stated, all the other chemicals were purchased
from Sigma.3. Results
3.1. SNAT2 silencing and inhibition of system A transport
activity
In untransfected ﬁbroblasts a 6 h-hypertonic treatment pro-
duced a 100% stimulation of the inﬂux of the speciﬁc system A
substrate MeAIB (Fig. 1, panel A). A 48 h-incubation with
scrambled siRNA lowered MeAIB inﬂux in both control and
hypertonically treated cells, although the hypertonic stimula-
tion was still clearly evident. On the contrary, transfection with
one of the three SNAT2 siRNAs tested (each at a concentra-
tion of 100 nM) severely hindered (SNAT2_2) or completely
abolished (SNAT2_1 and SNAT2_3) the hypertonic stimula-
tion of MeAIB inﬂux. The same treatment also lowered the ba-
sal activity of system A measured in cells maintained under
isotonic conditions.
A mixture of SNAT2_1 and SNAT2_3, each at a concentra-
tion of 50 nM, completely suppressed the hypertonic increase
of transport activity (Fig. 1, Panel B) after 48 h of transfection.T2 mRNA induction upon hypertonic stress. Human ﬁbroblasts were
procedure, cells were incubated in isotonic or hypertonic DMEM, as
r 48 h. After the incubation under isotonic or hypertonic conditions for
ere transfected with 50 nM SNAT2_1 and 50 nM SNAT2_3 or 100 nM
incubated under isotonic or hypertonic conditions for 6 h and MeAIB
cubated for 3 h under isotonic or hypertonic conditions, were employed
sfected as in (B) for 48 h. Threonine or aspartate inﬂux was measured
, and D, data are means ± S.D. of ﬁve independent determinations in a
parable results. In Panels A and B, statistical analysis was performed
rgone the same transfection procedure, but maintained under isotonic
m a representative experiment, repeated twice with comparable results.
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after a 24 h-transfection.
As expected from data in untransfected cells [13], a hyper-
tonic incubation of 3 h caused a clear cut increase of SNAT2
mRNA abundance in cells transfected with scrambled siRNA
(Fig. 1, Panel C). In contrast, no SNAT2 mRNA increase was
detected in ﬁbroblasts transfected with SNAT2_1 + SNAT2_3
siRNAs.
The speciﬁcity of system A inhibition by transfection with
SNAT2_1 and SNAT2_3 was assessed by determining the
activity of other sodium dependent, membrane potential sensi-
tive, transport systems for amino acids, such as system ASC
and system XAG, both operative in cultured human ﬁbroblasts
[11,12] and encoded by genes of SLC1 family [16]. No signiﬁ-
cant inhibition of both aspartate (system XAG) or threonine
(system ASC) inﬂux was observed in cells transfected with
SNAT2_1 + SNAT2_3 siRNAs compared to cells transfected
with scrambled siRNA (Fig. 1, Panel D).
3.2. SNAT2 siRNAs hinder cell volume recovery after
hypertonic stress
As shown in Fig. 2, the transfection with scrambled siRNA
did not prevent the hypertonic RVI expected in cultured hu-
man ﬁbroblasts [10]. Both control cell volume and initial
shrinkage, observed after the substitution of isotonic DMEM
with hypertonic DMEM, were comparable in cells transfected
with scrambled or antiSNAT2 siRNAs. In contrast, a compen-
satory swelling was progressively detectable only in cells trans-
fected with scrambled siRNA, whose volume was already
substantially restored after a 6 h-incubation. After 9 h of
hypertonic treatment, cell volume was not signiﬁcantly diﬀer-
ent from that of control cells, maintained in isotonic medium.
Under the same conditions, cells transfected with SNAT2_1
and SNAT2_3 siRNAs exhibited a severely delayed RVI. In-
deed, after 6 h of hypertonic treatment cells were still shrunken
with no signiﬁcant volume recovery while a little, but signiﬁ-
cant, compensatory response was only detectable after a 9 h-
incubation. At this experimental time, however, cells treatedFig. 2. Eﬀect of SNAT2 silencing on volume recovery of human
cultured ﬁbroblasts during hypertonic stress. Cells were transfected for
48 h with scrambled (100 nM) or with SNAT2_1 + SNAT2_3 siRNA
(each at 50 nM). Cells were then incubated in isotonic or hypertonic
DMEM, as indicated, for 9 h and cell volume was measured at the
indicated times, as described under Section 2. Data are means ± S.D.
of ﬁve independent determinations in a representative experiment
repeated three times with comparable results.with SNAT2 siRNAs were still markedly shrunken compared
with control cells maintained under isotonic conditions.
3.3. Changes in intracellular amino acids caused by SNAT2
siRNAs
Volume recovery of hypertonically stressed human ﬁbro-
blasts is associated to the expansion of the intracellular amino
acid pool [10]. After 6 h of hypertonic incubation the expected
changes in intracellular amino acids were indeed evident in
cells transfected with scrambled siRNA (Fig. 3, Panel A).
The intracellular content of all amino acids was higher in cells
incubated under hypertonic conditions than in cells main-
tained in isotonic medium (see also Table 1). In absolute terms,
the overall expansion of amino acid pool was almost 300 nmol/
mg of protein, with glutamine, a good substrate of system A in
human ﬁbroblasts [17], accounting for more than 50% of the
total increase (150 nmol/mg of protein). Transfection with
SNAT2-speciﬁc siRNAs (Fig. 3, Panel B) signiﬁcantly lowered
intracellular amino acids under isotonic conditions. Although
cell content of amino acids was still increased by hyperosmotic
stress (Table 1), the overall amount of amino acids accumu-
lated upon a 6 h-hypertonic incubation was lowered from
289 to 191 nmol/mg of protein. Under these conditions cell
glutamine content increased by only 87 nmol/mg of protein.4. Discussion
Until now, RNA interference has been employed only rarely
to suppress the expression of genes for amino acid transportersFig. 3. Eﬀect of SNAT2 silencing on the intracellular amino acid pool
in ﬁbroblasts incubated under isotonic or hypertonic conditions. Cells
were transfected with scrambled siRNA (Panel A) or the mixture of
SNAT2_1 + SNAT2_3 siRNA (Panel B) for 48 h. Cells were then
incubated for 6 h in isotonic or hypertonic DMEM, as indicated, and
the content of intracellular amino acids was measured as described
under Section 2. The contents of P, M, N, C, H, and W were <4 nmol/
mg of protein and not shown. Data are means ± S.D. of three
independent experiments.
Table 1
Changes of intracellular amino acids induced by hypertonic stress in cultured human ﬁbroblasts: eﬀect of SNAT2 silencing
Amino acids Scrambled siRNA SNAT2_1 + _3 siRNA
Absolute increase (nmol/mg of protein) % increase Absolute increase (nmol/mg of protein) % increase
Pool 289 62 191 56
D 7 20 8 33
T 20 102 14 80
S 14 71 9 75
E 23 17 30 24
Q 150 107 87 109
G 17 44 9 29
A 8 51 7 80
V 6 46 3 37
I + L 16 60 10 60
Y 6 72 3 52
F 6 70 3 65
K + R 8 71 6 109
Absolute increases have been obtained subtracting the values of the amino acid content of control cells, maintained under isotonic conditions, from
values obtained in hypertonically stressed ﬁbroblasts. Data are taken from Fig. 3.
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ployed to knockdown the expression of SLC38A2/SNAT2,
the ubiquitous isoform of transport system A, which has es-
caped so far silencing attempts by either gene knockout or
antisense oligos. The employment of siRNAs has yielded the
eﬀective silencing of SNAT2 not only under basal conditions
but also upon hypertonic stress, an experimental situation
associated with a marked induction of the gene [13,20].
Many transporters and enzymes have been involved in
osmocompensatory volume increase of mammalian cells
[1,2,5]. However, the absence of speciﬁc inhibitors has thus
far prevented the deﬁnition of the peculiar role played by each
operator in the volume recovery process. Through RNA inter-
ference we show here that SNAT2 suppression severely delays
cell volume recovery, thus pointing to an essential role of
SNAT2 induction in the short term restoration of cell volume
after hypertonic stress. These data also demonstrate that in-
creased SNAT2 mRNA abundance fully accounts for the stim-
ulation of transport activity of system A detected under
hypertonic conditions, thus indicating that the contribution
of additive mechanisms, such as regulation at post-transcrip-
tional or protein level, proposed for other osmotically sensitive
transporters [4], is marginal.
The link between transport change and volume recovery ap-
pears now fairly clear. The increased abundance of SNAT2
mRNA [20] is followed by the enhanced membrane expression
of SNAT2 protein [13]. The resulting transport stimulation is
followed by the expansion of the intracellular pool of both sys-
tem A substrates and other amino acids, through the opera-
tion of exchange mechanisms [7]. Amino acid accumulation
sustains the recovery of cell volume, thus lowering the osmot-
ically increased intracellular ionic strength. However, although
RNA interference abolishes hypertonic SNAT2 induction, a
limited, slow volume recovery is still detectable in anti-
SNAT2-siRNA transfected cells incubated under hypertonic
conditions. This residual compensatory response could be
attributed to other osmotically sensitive transporters, charac-
terized by delayed induction, such as BGT1 or SMIT [21].
Moreover, the increase in the intracellular amino acid pool
is markedly lowered but not completely suppressed by SNAT2
silencing. Indeed, although the amount of amino acids accu-
mulated by hypertonically stressed ﬁbroblasts is signiﬁcantlylowered by SNAT2 silencing, intracellular amino acids still
signiﬁcantly increase in relative terms under the same condi-
tion. This result suggests that another osmosensitive amino
acid transporter may somehow substitute the silenced SNAT2.
A possible candidate may be another SLC38 transporter, the
neuronal isoform SNAT1, whose expression in cultured hu-
man ﬁbroblasts is also stimulated upon hypertonic stress but
not aﬀected by anti SNAT2 siRNAs (E. Bevilacqua and R.
Sala, unpublished results).
SNAT2 expression is widespread and in many cell models
the activity of system A is up-regulated under hypertonic con-
ditions. Thus, the conclusions reached in this report may point
to a general clue of cell volume regulation in mammalian cells,
although the consequences of SNAT2 silencing in a speciﬁc cell
type will depend upon the transporter repertoire present there-
in. However, since failure to exert a rapid compensation of os-
motic shrinkage may have severe consequences on cell
proliferation and survival [22], the eﬀects of SNAT2 silencing
on cell viability and the expression of other stress-induced
genes deserve further investigation. Moreover, given that sys-
tem A is highly regulated under many physiological and path-
ological conditions [23], SNAT2 silencing may constitute a
precious experimental tool for a better understanding of the
functional role of the transporter.
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